Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 3

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Carcinoma, Non-Small-Cell Lung 18Breast Neoplasms 13Neoplasms 8Multiple Myeloma 8Melanoma 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Hematologic Neoplasms 6Urinary Bladder Neoplasms 5Prostatic Neoplasms 5Neoplasm Metastasis 5Leukemia, Lymphocytic, Chronic, B-Cell 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Thyroid Neoplasms 4Sarcoma 4Ovarian Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Adenocarcinoma 4Thyroid Cancer, Papillary 3Stomach Neoplasms 3Salivary Gland Neoplasms 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neurofibromatosis 1 3Neurofibroma, Plexiform 3Neuroendocrine Tumors 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3

Interventions

AZD 6244 2mirdametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has announcements × Neurofibroma, Plexiform × 90 days × Clear all
NCT01362803 2026-05-22

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
99 enrolled 1 FDA
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

NCT03962543 2026-05-06

ReNeu

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Phase 2 Active not recruiting
114 enrolled 25 charts 1 FDA
CNS

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

NCT04924608 2026-03-23

KOMET

AstraZeneca

Phase 3 Active not recruiting
145 enrolled 17 charts 1 FDA
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡